Clinical trials are registered on the ClinicalTrials.gov site through a web-based data entry system called the Protocol Registration and Results System (PRS). Some terms used in relation to accounts in the PRS include:
Any UW faculty, staff or student who is eligible to use the UW IRB for review of their studies may use the UW account to register clinical trials in which the UW is engaged in the research, even for trials that were reviewed by a non-UW IRB instead of the UW IRB.
To create your user account, following the instructions outlined in the SOP Creating a CT.gov User Account. Requests for a new user account are usually completed within 2 business days once the Regulatory Affairs team receives the request.
To assist researchers, HSD has linked to CT.gov Quick Overview Guides from the PRS site.
General information on different PRS roles and responsibilities can be found in section 3.1 of the PRS User’s Guide. The following provides UW-specific information:
Sponsor (or Sponsor Organization) – The UW is a Sponsor Organization; it is listed in the PRS system as UWashington.
Administrator – HSD’s Regulatory Affairs team serves as the Administrator for the UWashington account. Contact them through hsdreprt@uw.edu.
Responsible Party – The UW PI should be identified as the Responsible Party for studies reviewed by HSD. For studies managed under the Fred Hutch/UW Cancer Consortium, a PI who initiates or conducts an investigator-initiated clinical trial is designated as the Responsible Party, but the Responsible Party for other types of interventional trials is usually the Sponsor.
HSD reviews all incoming IRB applications and certain study modifications to determine whether the study is required to register and report results on CT.gov. The Regulatory Affairs staff at HSD will send an email to the study team if the trial meets these requirements and outline the steps for completing registration.
If the study is required to register in PRS, Regulatory Affairs staff will initiate the trial registration for the PI in PRS. The PI will need to complete the registration in PRS no later than 21 days after enrollment of the first study participant or within 1 year of IRB approval (HSD Policy), whichever occurs first. Registration is completed when a National Clinical Trial (NCT) number has been assigned to the study record.
Generally, each IRB application will have its own PRS study registration. However, contact HSD at hsdreprt@uw.edu regarding unique situations that may require more than one study registration for a study (e.g., NIH requests two separate registrations). Include ‘CT.gov’ in the subject line of your email to help triage your message efficiently.
After receiving the email from the Regulatory Affairs staff regarding initiation of trial registration, log into the PRS system to enter data and complete registration. Information is entered by the study team in the trial record by completing a series of topic-specific sections (called modules) in the ‘Protocol Section’ located on the ‘Record Summary’ page.
The following documents and links provide guidance and instructions on how to enter data into the modules:
Additional resources from CT.gov:

Section 8 of the PRS User’s Guide describes how to identify and resolve records with problems.
For specific questions related to data entry or registration issues for your specific trial, we recommend contacting register@clinicaltrials.gov for assistance.
For general questions, contact HSD at hsdreprt@uw.edu for assistance. Include ‘CT.gov’ in the subject line of your email to help triage your message efficiently.
For assistance with studies managed by the Cancer Consortium’s Clinical Research Support (CRS) Office, contact CRS at CTgov@fredhutch.org. More information can also be found on the CRS webpage.